Polycomb-mediated silencing in neuroendocrine prostate cancer

@inproceedings{Clermont2015PolycombmediatedSI,
  title={Polycomb-mediated silencing in neuroendocrine prostate cancer},
  author={Pier-Luc Clermont and D T S Lin and Francesco Crea and Rebecca Chung-Fern Wu and Hui Xue and Yuwei Wang and Kelsie L. Thu and Wan L. Lam and Colin Collins and Yuzhuo Wang and Cheryl D. Helgason},
  booktitle={Clinical Epigenetics},
  year={2015}
}
Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer (PCa) for which the median survival remains less than a year. Current treatments are only palliative in nature, and the lack of suitable pre-clinical models has hampered previous efforts to develop novel therapeutic strategies. Addressing this need, we have recently established the first in vivo model of complete neuroendocrine transdifferentiation using patient-derived xenografts. Few genetic differences… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 70 references

how polycomb proteins regulate neurogenesis

  • Testa G. The time of timing
  • Bioessays. 2011;33:519–28. Clermont et al…
  • 2015
2 Excerpts

Similar Papers

Loading similar papers…